Selected research
Industry Research
Acyl CoA Desaturase Industry Research Report 2026
Market perspective
The global Acyl CoA Desaturase market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Acyl CoA Desaturase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Acyl CoA Desaturase is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Acyl CoA Desaturase is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Acyl CoA Desaturase include Sanofi, Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc, Xenon Pharmaceuticals Inc., Thesan Pharmaceuticals, Inc., Galmed Pharmaceuticals Ltd and Daiichi Sankyo Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Acyl CoA Desaturase market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Acyl CoA Desaturase Market by Company
Sanofi
Johnson & Johnson
Novartis AG
GlaxoSmithKline Plc
Xenon Pharmaceuticals Inc.
Thesan Pharmaceuticals, Inc.
Galmed Pharmaceuticals Ltd
Daiichi Sankyo Co Ltd
Acyl CoA Desaturase Segment by Type
Aramchol
TSN-2898
T-3764518
Others
Acyl CoA Desaturase Segment by Application
Metastatic Renal Cell Carcinoma
Acne Vulgaris
Colorectal Cancer
Liver Fibrosis
Others
Acyl CoA Desaturase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acyl CoA Desaturase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acyl CoA Desaturase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acyl CoA Desaturase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Acyl CoA Desaturase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Acyl CoA Desaturase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Acyl CoA Desaturase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aramchol
- TSN-2898
- T-3764518
- Others
Applications
- Metastatic Renal Cell Carcinoma
- Acne Vulgaris
- Colorectal Cancer
- Liver Fibrosis
- Others
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis AG
- GlaxoSmithKline Plc
- Xenon Pharmaceuticals Inc.
- Thesan Pharmaceuticals, Inc.
- Galmed Pharmaceuticals Ltd
- Daiichi Sankyo Co Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Acyl CoA Desaturase Market Size (2021-2032)
- 2.2.2 Global Acyl CoA Desaturase Sales (2021-2032)
- 2.2.3 Global Acyl CoA Desaturase Market Average Price (2021-2032)
- 2.3 Acyl CoA Desaturase by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aramchol
- 2.3.3 TSN-2898
- 2.3.4 T-3764518
- 2.3.5 Others
- 2.4 Acyl CoA Desaturase by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Metastatic Renal Cell Carcinoma
- 2.4.3 Acne Vulgaris
- 2.4.4 Colorectal Cancer
- 2.4.5 Liver Fibrosis
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Acyl CoA Desaturase Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Acyl CoA Desaturase Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Acyl CoA Desaturase Revenue of Manufacturers (2021-2026)
- 3.4 Global Acyl CoA Desaturase Average Price by Manufacturers (2021-2026)
- 3.5 Global Acyl CoA Desaturase Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Acyl CoA Desaturase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Acyl CoA Desaturase, Product Type & Application
- 3.8 Global Manufacturers of Acyl CoA Desaturase, Established Date
- 3.9 Global Acyl CoA Desaturase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Acyl CoA Desaturase Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Acyl CoA Desaturase Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis AG
- 4.3.1 Novartis AG Company Information
- 4.3.2 Novartis AG Business Overview
- 4.3.3 Novartis AG Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis AG Acyl CoA Desaturase Product Portfolio
- 4.3.5 Novartis AG Recent Developments
- 4.4 GlaxoSmithKline Plc
- 4.4.1 GlaxoSmithKline Plc Company Information
- 4.4.2 GlaxoSmithKline Plc Business Overview
- 4.4.3 GlaxoSmithKline Plc Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Plc Acyl CoA Desaturase Product Portfolio
- 4.4.5 GlaxoSmithKline Plc Recent Developments
- 4.5 Xenon Pharmaceuticals Inc.
- 4.5.1 Xenon Pharmaceuticals Inc. Company Information
- 4.5.2 Xenon Pharmaceuticals Inc. Business Overview
- 4.5.3 Xenon Pharmaceuticals Inc. Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Xenon Pharmaceuticals Inc. Acyl CoA Desaturase Product Portfolio
- 4.5.5 Xenon Pharmaceuticals Inc. Recent Developments
- 4.6 Thesan Pharmaceuticals, Inc.
- 4.6.1 Thesan Pharmaceuticals, Inc. Company Information
- 4.6.2 Thesan Pharmaceuticals, Inc. Business Overview
- 4.6.3 Thesan Pharmaceuticals, Inc. Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Thesan Pharmaceuticals, Inc. Acyl CoA Desaturase Product Portfolio
- 4.6.5 Thesan Pharmaceuticals, Inc. Recent Developments
- 4.7 Galmed Pharmaceuticals Ltd
- 4.7.1 Galmed Pharmaceuticals Ltd Company Information
- 4.7.2 Galmed Pharmaceuticals Ltd Business Overview
- 4.7.3 Galmed Pharmaceuticals Ltd Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Galmed Pharmaceuticals Ltd Acyl CoA Desaturase Product Portfolio
- 4.7.5 Galmed Pharmaceuticals Ltd Recent Developments
- 4.8 Daiichi Sankyo Co Ltd
- 4.8.1 Daiichi Sankyo Co Ltd Company Information
- 4.8.2 Daiichi Sankyo Co Ltd Business Overview
- 4.8.3 Daiichi Sankyo Co Ltd Acyl CoA Desaturase Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Daiichi Sankyo Co Ltd Acyl CoA Desaturase Product Portfolio
- 4.8.5 Daiichi Sankyo Co Ltd Recent Developments
5 Global Acyl CoA Desaturase Market Scenario by Region
- 5.1 Global Acyl CoA Desaturase Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Acyl CoA Desaturase Sales by Region: 2021-2032
- 5.2.1 Global Acyl CoA Desaturase Sales by Region: 2021-2026
- 5.2.2 Global Acyl CoA Desaturase Sales by Region: 2027-2032
- 5.3 Global Acyl CoA Desaturase Revenue by Region: 2021-2032
- 5.3.1 Global Acyl CoA Desaturase Revenue by Region: 2021-2026
- 5.3.2 Global Acyl CoA Desaturase Revenue by Region: 2027-2032
- 5.4 North America Acyl CoA Desaturase Market Facts & Figures by Country
- 5.4.1 North America Acyl CoA Desaturase Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Acyl CoA Desaturase Sales by Country (2021-2032)
- 5.4.3 North America Acyl CoA Desaturase Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Acyl CoA Desaturase Market Facts & Figures by Country
- 5.5.1 Europe Acyl CoA Desaturase Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Acyl CoA Desaturase Sales by Country (2021-2032)
- 5.5.3 Europe Acyl CoA Desaturase Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Acyl CoA Desaturase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Acyl CoA Desaturase Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Acyl CoA Desaturase Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Acyl CoA Desaturase Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Acyl CoA Desaturase Market Facts & Figures by Country
- 5.7.1 South America Acyl CoA Desaturase Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Acyl CoA Desaturase Sales by Country (2021-2032)
- 5.7.3 South America Acyl CoA Desaturase Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Acyl CoA Desaturase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Acyl CoA Desaturase Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Acyl CoA Desaturase Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Acyl CoA Desaturase Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Acyl CoA Desaturase Sales by Type (2021-2032)
- 6.1.1 Global Acyl CoA Desaturase Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Acyl CoA Desaturase Sales Market Share by Type (2021-2032)
- 6.2 Global Acyl CoA Desaturase Revenue by Type (2021-2032)
- 6.2.1 Global Acyl CoA Desaturase Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Acyl CoA Desaturase Revenue Market Share by Type (2021-2032)
- 6.3 Global Acyl CoA Desaturase Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Acyl CoA Desaturase Sales by Application (2021-2032)
- 7.1.1 Global Acyl CoA Desaturase Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Acyl CoA Desaturase Sales Market Share by Application (2021-2032)
- 7.2 Global Acyl CoA Desaturase Revenue by Application (2021-2032)
- 7.2.1 Global Acyl CoA Desaturase Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Acyl CoA Desaturase Revenue Market Share by Application (2021-2032)
- 7.3 Global Acyl CoA Desaturase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Acyl CoA Desaturase Value Chain Analysis
- 8.1.1 Acyl CoA Desaturase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Acyl CoA Desaturase Production Mode & Process
- 8.2 Acyl CoA Desaturase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Acyl CoA Desaturase Distributors
- 8.2.3 Acyl CoA Desaturase Customers
9 Global Acyl CoA Desaturase Analyzing Market Dynamics
- 9.1 Acyl CoA Desaturase Industry Trends
- 9.2 Acyl CoA Desaturase Industry Drivers
- 9.3 Acyl CoA Desaturase Industry Opportunities and Challenges
- 9.4 Acyl CoA Desaturase Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst